Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 9/2014

01-09-2014 | SPONDYLOARTHRITIS (MA KHAN, SECTION EDITOR)

Seronegative Arthritis in Latin America: A Current Review

Authors: Carla Gonçalves Schain Saad, Célio Roberto Gonçalves, Percival D. Sampaio-Barros

Published in: Current Rheumatology Reports | Issue 9/2014

Login to get access

Abstract

In many Latin American countries seronegative arthritis, especially the spondyloarthritides (SpA), is commonly characterized by associated axial and peripheral involvement. In this article, the authors review the ethnic distribution of the population and the different SpA in 10 Latin American countries, and the main characteristics of the Ibero-American Registry of Spondyloarthropathies (RESPONDIA) compared with other international registries. The peripheral component of SpA is more frequent in mixed-race populations, whereas psoriatic arthritis is significantly more frequent in countries with predominantly white populations.
Literature
1.
Espinoza LR, Toloza SM, Valle-Onate R, Mease PJ. Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012;39:445–7.PubMedCrossRef
2.•
Benegas M, Muñoz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39:2315–20. This article, comparing 1,083 Latin American (from nine countries) and 2,356 European patients (from Spain and Belgium), shows that the Latin American patients were characterized by a higher frequency of peripheral involvement and enthesitis whereas the European patients had a significantly higher percentage of positive HLA-B27.PubMedCrossRef
3.
Vander Cruyssen B, Muñoz-Gomariz E, Font P, Mulero J, de Vlam K, Boonen A, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49:73–81.CrossRef
4.
Pérez Alamino R, Maldonado Cocco JA, Citera G, Arturi P, Vazquez-Mellado J, Sampaio-Barros PD, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory disease. J Rheumatol. 2011;38:1656–60.PubMedCrossRef
5.
Sampaio-Barros PD, Pereira IA, Hernández-Cuevas C, Berman A, Burgos-Vargas R, Gutierrez MA, et al. An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA group. Clin Exp Rheumatol. 2013;31:484–9.PubMed
6.
Gallinaro AL, Ventura C, Sampaio Barros PD, Gonçalves CR. Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group). Braz J Rheumatol. 2010;50:581–9.
7.
Buschiazzo E, Maldonado-Cocco JA, Arturi P, Citera G, Berman A, Nitsche A, et al. Epidemiology of spondyloarthritis in Argentina. Am J Med Sci. 2011;341:289–92.PubMedCrossRef
8.
Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford). 2011;50:729–34.CrossRef
9.
Arturi P, Schneeberger EE, Sommerfleck F, Buschiazzo E, Ledesma C, Maldonado Cocco JA, et al. Adherence to treatment in patients with ankylosing spondylitis. Clin Rheumatol. 2013;32:1007–15.PubMedCrossRef
10.
Skare TL, Bortoluzzo AB, Gonçalves CR, Braga da Silva JA, Ximenes AC, Bértolo MB, et al. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol. 2012;39:141–7.PubMedCrossRef
11.
de Carvalho HM, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, Bértolo MB, et al. Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol. 2012;31:687–95.PubMedCrossRef
12.
Skare TL, Leite N, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, et al. Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. Clin Exp Rheumatol. 2012;30:351–7.PubMed
13.•
Carneiro S, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, Bértolo MB, et al. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis. J Rheumatol. 2013;40:1719–25. This article reveals that when the MASES was applied to a group of 1,505 Brazilian patients with SpA, 54 % had at least one affected enthesis. Achilles enthesitis also was associated with work incapacity in the multivariate logistic regression analysis.PubMedCrossRef
14.
Bonfiglioli R, Carneiro S, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, et al. Characteristics of psoriatic arthritis in a large cohort of Brazilian patients with spondyloarthritis. Braz J Rheumatol. 2014; submitted to publication.
15.
Favarato MH, Mease P, Gonçalves CR, Gonçalves Saad C, Sampaio-Barros PD, Goldenstein-Schainberg C. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis. Clin Exp Rheumatol. 2014; 32:182–7.
16.
Lanna CC, Ferrari ML, Rocha SL, Nascimento E, de Carvalho MM, da Cunha AS. A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol. 2008;27:503–9.PubMedCrossRef
17.
Resende GG, Lanna CC, Bortoluzzo AB, Gonçalves CR, Braga da Silva JA, Ximenes AC, et al. Enteropathic arthritis in Brazil: data from the Brazilian Registry of Spondyloarthritis. Braz J Rheumatol. 2013;53:452–6.
18.
Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LT, Samara AM, Bértolo MB. Undifferentiated spondyloarthritis: a long-term follow-up. J Rheumatol. 2010;37:1195–9.PubMedCrossRef
19.
Lage RC, Bomtempo CAS, Kakehasi AM, de Carvalho MA. Undifferentiated spondyloarthritis in a heterogeneous Brazilian population: an eight-year follow-up study. Rheumatol Int. 2013 Jun 14 (E-pub ahead of print).
20.
Sampaio-Barros PD, Santiago MB, Bortoluzzo AB, Ximenes AC, Braga da Silva JA, Bértolo MB, et al. Combined axial and peripheral involvement is associated with miscegenation in a large and heterogenoeus Brazilian cohort of 1505 patients with spondyloarthritis. Arthritis Rheum. 2013;65:S1056.
21.
Saad CG, Ribeiro AC, Moraes JC, Takayama L, Gonçalves CR, Rodrigues MB, et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis Res Ther. 2012;14:R216.PubMedCrossRefPubMedCentral
22.
Sampaio-Barros PD, Keiserman M, Meirelles ES, Pinheiro MM, Ximenes AC, Azevedo VF, et al. Recommendations for the management and treatment of ankylosing spondylitis. Braz J Rheumatol. 2013;53:242–57.
23.
Carneiro S, Azevedo VF, Bonfiglioli R, Ranza R, Gonçalves CR, Keiserman M, et al. Recommendations for the management and treatment of psoriatic arthritis. Braz J Rheumatol. 2013;53:227–41.
24.
Gutierrez MA, Pérez C, Saavedra J, Silva F, Fuentealba C, Pozo P, et al. Registro Iberoamericano de Espondiloartritis: Chile. Reumatol Clin. 2008;4 Suppl 4:S41–7.
25.
Valenzuela F, Silva P, Valdés MP, Papp K. Epidemiology and quality of life of patients with psoriasis in Chile. Actas Dermosifiliogr. 2011;102:810–6.PubMedCrossRef
26.
Valle-Oñate R, Candia L, Romero-Sánchez C, Iglesias-Gamarra A, Caballero-Uribe CV, Santos-Moreno P, et al. Epidemiology of spondyloarthritis in Colombia. Am J Med Sci. 2011;341:293–4.PubMedCrossRef
27.
Romero-Sánchez C, Londoño J, Delgado G, Jaimes DA, De Avila J, Mora A, et al. Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia. Rheumatol Int. 2012;32:2195–7.PubMedCrossRef
28.
Londoño J, Romero-Sanchez MC, Torres VG, Bautista WA, Fernandez DJ, Quiroga JA, et al. The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis. Braz J Rheumatol. 2012;52:536–44.
29.
Romero-Sánchez C, Robinson WH, Tomooka BH, Londoño J, Valle-Oñate R, Huang F, et al. Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol. 2008;27:1429–35.PubMedCrossRef
30.
Saenz-Castro R. Registro Iberoamericano de Espondiloartritis: Costa Rica. Reumatol Clin. 2008;4 Suppl 4:S36–40.
31.
Garcia-Kutzbach A, Montenegro A, Iraheta I, Bará C, Saenz R. Epidemiology of spondyloarthropathies in Central America. Am J Med Sci. 2011;341:295–7.PubMedCrossRef
32.•
Peláez-Ballestas I, Navarro-Zarza JE, Julian J, Lopez A, Flores-Camacho R, Casasola-Vargas JC, et al. A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans. J Clin Rheumatol. 2013;19:57–61. This study analyzed the results of a door-to-door nurse survey applying the Community Oriented Program for the Control of Rheumatic Diseases (COPCORD) to 4,059 individuals in Mexico City. The prevalence of back pain was 14.6 %, whereas the prevalence of inflammatory back pain was 1.3 % and that of AS was 0.6 %.PubMedCrossRef
33.
Burgos-Vargas R, Peláez-Ballestas I. Epidemiology of spondyloarthritis in Mexico. Am J Med Sci. 2011;341:298–300.PubMedCrossRef
34.
Huerta-Sil G, Casasola-Vargas JC, Londoño JD, et al. Low-grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis. 2003;65:642–6.CrossRef
35.
Chavez-Corrales JE, Jauregui MM, Linares MA, Mora C, Valencia PR, Garcia E, et al. Registro Iberoamericano de Espondiloartritis: Peru. Reumatol Clin. 2008;4 Suppl 4:S63–7.
36.
Toloza SM, Vega-Hinojosa O, Chandran V, Valle-Onate R, Espinoza LR. Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting. J Rheumatol. 2012;39:2216–9.PubMedCrossRef
37.
Palleiro D, Spangenberg E. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Uruguay. Reumatol Clin. 2008;4 (Suppl 4):S73–8.
38.
Chacón R, Granados Y, Esteva MH, Martinez Y, Maldonado T, Rondón J, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Venezuela. Reumatol Clin. 2008;4 (Suppl 4):S79–86.
Metadata
Title
Seronegative Arthritis in Latin America: A Current Review
Authors
Carla Gonçalves Schain Saad
Célio Roberto Gonçalves
Percival D. Sampaio-Barros
Publication date
01-09-2014
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 9/2014
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-014-0438-3

Other articles of this Issue 9/2014

Current Rheumatology Reports 9/2014 Go to the issue

Orphan Diseases (B Manger, Section Editor)

Pachydermodactyly: A Review

Systemic Lupus Erythematosus (M Petri, Section Editor)

Rituximab and Lupus – A Promising Pair?

Vasculitis (L Espinoza, Section Editor)

Vasculitis in Systemic Lupus Erythematosus

Pediatric Rheumatology (S Ozen, Section Editor)

Genetic Defects in Cytolysis in Macrophage Activation Syndrome

Psoriatic Arthritis (O FitzGerald and P Helliwell, Section Editors)

Novel Treatments with Small Molecules in Psoriatic Arthritis

Systemic Lupus Erythematosus (M Petri, Section Editor)

Treatment of Osteonecrosis in Systemic Lupus Erythematosus: A Review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits